Senior Consultant David Cooney gives speech on the future of precision medicine

Blue Latitude Health|16th March 2018

The clinical value precision medicines promises is widely recognised as the future of healthcare, but the inherent complexity of introducing these treatments and incorporating them into clinical practice is challenging for both industry and academia.

On 14 March 2018, Senior Consultant David Cooney arrived in Dublin, Ireland, to talk to key industry players about some of the challenges experienced by those developing precision medicines.

He presented an enlightening speech on ‘Understanding the opportunity of precision medicine’ at The National Pharmaceutical & Life Sciences Expo, held at the Citywest Exhibition Centre.

The presentation set out the differences between personalised and precision medicine. Importantly, David focused on the commercial challenges and opportunities for those at the forefront of innovation.

"It was really inspiring to see how advanced Ireland is in precision medicine, and how many people are taking a design thinking approach to solving complex healthcare problems"

This included, making the business case for precision medicine and exploring how the industry can help support the implementation and adoption of these innovative treatments.

He also analysed important hot topics, including the role of big data in overcoming market access challenges and delivering better patient outcomes.

More than 1,000 senior managers from the pharmaceutical and life sciences industry attended the event, taking the opportunity to learn about the latest innovations in healthcare.

David said: “It was really inspiring to see how advanced Ireland is in precision medicine, and how many people are taking a design thinking approach to solving complex healthcare problems.”

To learn more about how we support our clients in launching innovative therapies, contact david.cooney@bluelatitude.com

If you are interested in this topic, take a look at our recent articles and sign up for our newsletter here.

What it means to be a CALM company

Jack Reinsfield|20th March 2019

Blue Latitude sits down with CALM’s Director of Corporate Partnerships, Andrew Brown, to talk about what CALM does, how to sustainably safeguard mental health in the workplace, and what it means to be a CALM company.

read more

Why we're running: London Marathon 2019

Jack Reinsfield|8th March 2019

This year, seven staff members at Blue Latitude Health will be running in the London Marathon, and fundraising for Bloodwise UK. This is why we're running. 

read more

Building a career at BLH

Jack Reinsfield|4th March 2019

Jack Reinsfield sits down with Will Taylor to map his journey at Blue Latitude Health from Account Executive to Senior Account Manager on one of our biggest accounts.

read more